Impact of Cyclooxygenase Inhibitors in the Women's Health Initiative Hormone Trials: Secondary Analysis of a Randomized Trial

• Judith Hsia ,

  *To whom correspondence should be addressed. E-mail: jhsia@mfa.gwu.edu

  Affiliation Department of Medicine, George Washington University, Washington, D. C., United States of America

  ⨯
• JoAnn E Manson,

  Affiliation Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Lewis Kuller,

  Affiliation Department of Epidemiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States of America

  ⨯
• Mary Pettinger,

  Affiliation Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America

  ⨯
• John H Choe,

  Affiliation Department of Medicine, University of Washington, Seattle, Washington, United States of America

  ⨯
• Robert D Langer,

  Affiliation Department of Family Medicine, University of California San Diego, La Jolla, California, United States of America

  ⨯
• Marian Limacher,

  Affiliation Department of Medicine, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Albert Oberman,

  Affiliation Department of Medicine, University of Alabama Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Judith Ockene,

  Affiliation Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, United States of America

  ⨯
• Mary Jo O'Sullivan,

  Affiliation Department of Obstetrics and Gynecology, University of Miami, Miami, Florida, United States of America

  ⨯
• Jennifer G Robinson,

  Affiliation Department of Medicine, University of Iowa, Iowa City, Iowa, United States of America

  ⨯
• for the Women's Health Initiative Research